Amaia
Vilas Zornoza
Researcher to 2022
Hamad Medical Corporation
Doha, QatarPublications in collaboration with researchers from Hamad Medical Corporation (2)
2021
-
Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma
Leukemia, Vol. 35, Núm. 5, pp. 1438-1450
2020
-
Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma
Genome Research, Vol. 30, Núm. 9, pp. 1217-1227